Results 41 to 41 of about 41 (41)

Durvalumab combined with concurrent chemoradiotherapy in patients with limited‐stage small cell lung cancer: A prospective, single‐arm, phase 2 clinical trial

Cancer, Volume 132, Issue 6, 15 March 2026.
Abstract Background The current standard treatment for limited‐stage small cell lung cancer (LS‐SCLC) is concurrent chemoradiotherapy (cCRT) plus consolidation immunotherapy, with or without prophylactic cranial irradiation (PCI). However, it remains unknown whether administering immunotherapy concurrently with chemoradiotherapy confers additional ...
Chunyang Song, Xiaohan Zhao, Shuguang Li, Xuehan Guo, Xueyuan Zhang, Xiaobin Wang, Youmei Li, Ke Yan, Jingwei Su, Jinrui Xu, Shuchai Zhu, Wenbin Shen   +11 more
wiley   +1 more source